Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies
Abstract After being stagnant for decades, there has finally been a paradigm shift in the treatment of cancer with the emergence and application of immune checkpoint inhibitors (ICIs). The most extensively utilized ICIs are targeting the pathways involving programmed death-1 (PD-1) and cytotoxic T-l...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4737bbfa432544ec8485c334fc35df4d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|